Replies to post #13468 on Biotech Values

[spartex]

Hi Dew-- re: DNDN comments

>>However, events of the past six months are also consistent with the 9902a survival data being mediocre and DNDN’s scrambling to control the damage.<<

You have been valuable at finding links to news on biotechs as well as your Q's on conf. calls and inquiry with companies you invest in. Could you share what news you've discovered that would indicate that DNDN may have mediocre 9902a survival data as well as company scrambling to control the damage?

The yahoo board holligans aside, there were a few posters mentioning that DNDN is on a so-called "road show" with various analysts or investment banks.

Any news you could share would be most appreciated.

Thanks!